Genomics, or the study of genes and their function, is a burgeoning field w
ith many new technologies. In the present review, we explore the applicatio
n of genomic approaches to the study of pulmonary hypertension (PH). Candid
ate genes, important to the pathobiology of the disease, have been investig
ated. Rodent models enable the manipulation of selected genes, either by tr
ansgenesis or targeted disruption. Mutational analysis of genes in the tran
sforming growth factor-beta family have proven pivotal in both familial and
sporadic forms of primary PH. Finally, microarray gene expression analysis
is a robust molecular tool to aid in delineating the pathobiology of this
disease.